Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
But price controls on medicines could put this progress at risk.
Our Perspective
The 2026 Health Summit convened business, policy, and innovation leaders around a shared agenda: modernizing America's health system as a strategic economic asset
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Latest Content
- For the second consecutive year, senior government officials, health ministers, and private sector leaders gather in New York to chart the path forward on U.S. global health diplomacy.Access to information empowers consumers, strengthens competition, and helps new ideas reach the marketplace.Consumer healthcare advertising promotes patient awareness, market competition, medical innovation, and economic growth.At an executive-level U.S. Chamber roundtable, leaders from government, healthcare, and industry found common ground on the policies and principles needed to advance AI in healthcare responsibly.Drug development systems can be made dramatically more efficient without sacrificing the standards that earn public trust.A little-known CMS policy shift is putting future medical breakthroughs, and patients’ access to better care, at risk.GLP-1 medicines are transforming obesity care, but price controls could undermine innovation, access, and future cures.
